Nyheder og presse

Prevena^™ Incision Management System now available to all U.S. hospitals

Prevena^™ Incision Management System now available to all U.S. hospitals

Court Finds Smith & Nephew's Renasys EZ Product Infringes KCI Patent; Issues Injunction

UK High Court of Justice Enters Injunction Against Smith & Nephew’s NPWT Products; Injunction Stayed Pending Expedited Appeal

UK High Court of Justice Finds Smith & Nephew's Products Infringe Two NPWT Patents Exclusively Owned By KCI

Designed to Help Manage Patients' Incisions Successfully Following Surgery

Postsurgical Incision Management Represents $1 Billion Global Market Opportunity: U.S. Approval Follows Prevena^™ System Launch in Europe and Canada

Move Signals KCI's Support of FDA's Goal of Ensuring Strong Standards for Patient Home Use

Extends KCI's Reach Across All Three Major Chronic Wound Types

New insights from global experts on pressure ulcers to be released at the 20th Conference of the European Wound Management Association (EWMA) in Geneva

KCI will launch its full range of new NPTP products and support the release of a consensus document on pressure ulcer prevention titled International Review - Pressure, Shear, Friction and Microclimate in Context

Latest Innovation Provides Groundbreaking Design in Negative Pressure Wound Therapy

Will Oversee Global Market Development for Negative Pressure Technology Platform

Negative Pressure Symposium and Conference Exhibit to Focus on KCI's Ongoing Commitment to Improve and Simplify Negative Pressure Treatments

Prevena^™ System First and Only Powered Negative Pressure Product Designed to Manage Incisions at Risk of Complication

Disaster has a way of bringing us together. Today KCI has come together as a company to address the significant needs of the people in Haiti. As you know, KCI has been able to donate our products, and now we’d like to help stretch the impact of donations employees may choose to make to the Haiti relief efforts.

Formal regulatory approval enables commercialization of innovative V.A.C.® Therapy System in Japan.

Kinetic Concepts, Inc. (NYSE: KCI) today reported third quarter 2009 total revenue of $504.4 million, compared to $503.3 million reported for the third quarter of 2008.

Grant celebrates the conception of Negative Pressure Wound Therapy

Hosts Open Abdomen Management Symposium Featuring Top Surgical, Critical Care Experts

Kinetic Concepts, Inc. (NYSE:KCI) announced today that the Full Court of The Federal Court of Australia, Victoria District Registry has lifted a temporary injunction in KCI’s patent litigation with Smith & Nephew (LSE: SN, NYSE: SNN). The temporary injunction, which was issued in June 2009, prohibited Smith & Nephew from selling foam dressing kits for negative pressure wound therapy (NPWT) in Australia. The temporary injunction is being lifted until the trial court can rule on the merits of the patent infringement case. The trial on the merits is scheduled to take place in June 2010. KCI is seeking monetary damages and permanent injunctive relief against Smith & Nephew in Australia for the marketing and sale of NPWT dressing kits which KCI believes infringe a patent licensed to KCI from Wake Forest University Health Sciences.

Company Also Introduces New U.S. Open Abdomen Management System Clinical Guidelines

Ahmed and Mohamed Ibrahim, the eight-year-old craniopagus twins successfully separated during a well-documented and risky 34-hour operation in 2003, will visit Kinetic Concepts Inc. (KCI) Friday for a celebratory reunion.

Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.

KCI announced today that it has been informed by the Pharmaceutical and Medical Devices Agency in Japan that in October the Ministry of Health, Labor and Welfare will grant regulatory approval for KCI to begin market development activities in Japan for its innovative V.A.C.^® Therapy product.

Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference 2009 at the Four Seasons Hotel in Boston, Massachusetts.

Kinetic Concepts, Inc. (NYSE: KCI), today announced the official launch of ABThera™ open abdomen negative pressure therapy system, the latest addition to its Negative Pressure Technology Platform (NPTP).

Kinetic Concepts, Inc. (NYSE: KCI) today announced that the U.S. Patent and Trademark Office (USPTO) issued Office actions confirming the validity of three separate patents licensed to KCI by Wake Forest University Health Sciences in re-examination proceedings.

Kinetic Concepts, Inc. (NYSE: KCI) announced today that Michael Genau has joined the Company in the newly formed position of Global President, Wound Therapy.

Kinetic Concepts, Inc. (NYSE: KCI) announced today that the Court of Appeal of England and Wales has revoked a patent licensed to KCI from Wake Forest University.

Improving wound care in the community may be the fastest route to reach some of Lord Darzi’s proposed quality improvements for the NHS. And using KCI’s V.A.C.®

Kinetic Concepts, Inc. (NYSE:KCI), today announced that it will report its second quarter 2009 financial results on Tuesday, July 21, 2009, at 6:00 a.m. EDT.

Kinetic Concepts, Inc. (NYSE: KCI) announced today that The Federal Court of Australia, Victoria District Registry, issued a temporary injunction prohibiting Smith & Nephew (LSE: SN; NYSE: SNN) from selling foam dressing kits for negative pressure wound therapy in Australia until the court can rule on the patent infringement action brought against Smith & Nephew by KCI.

Kinetic Concepts, Inc. in conjunction with The York Health Economics Consortium (YHEC) will launch a new Budget Impact Model (BIM) for wound care surfaces at the European Wound Management Association (EWMA) Conference in Helsinki .

KCI announced today the U.S. market launch of its new V.A.C.^® GranuFoam™ Bridge Dressing, further expanding the portfolio of dressings used in the treatment of chronic wounds. This new dressing is expected to simplify application in chronic wounds, especially Diabetic Foot Ulcers (DFUs) where it is compatible with off-loading devices.

Kinetic Concepts, Inc. (NYSE:KCI) announced today that a temporary injunction against Smith & Nephew has been granted by the Specialist Patents Court in the High Court of Justice of England and Wales.

Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco.